Effect of IL-17 Monoclonal Antibody Secukinumab Combined With IL-35 Blockade of Notch Signaling Pathway on the Invasive Capability of Hepatoma Cells

Genetics and Molecular Research - Brazil
doi 10.4238/gmr.15028174
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Genetics and Molecular Research

Related search

Effect of Interleukin (IL)-35 on IL-17 Expression and Production by Human CD4+ T Cells

PeerJ
GeneticsMolecular BiologyBiochemistryBiological SciencesMedicineAgriculturalNeuroscience
2017English

IL-17RD (Sef or IL-17RLM) Interacts With IL-17 Receptor and Mediates IL-17 Signaling

Cell Research
Cell BiologyMolecular Biology
2008English

IL-17 Enhancement of the IL-6 Signaling Cascade in Astrocytes

Journal of Immunology
AllergyImmunology
2010English

Autophagy Impacts on Oxaliplatin-Induced Hepatocarcinoma Apoptosis via the IL-17/IL-17R-JAK2/STAT3 Signaling Pathway

Oncology Letters
Cancer ResearchOncology
2016English

The Advent of IL-17A Blockade in Ankylosing Spondylitis: Secukinumab, Ixekizumab and Beyond

Expert Review of Clinical Immunology
AllergyImmunology
2019English

TRAF Regulation of IL-17 Cytokine Signaling

Frontiers in Immunology
AllergyImmunology
2019English

Association of Combined IL-13/IL-4R Signaling Pathway Gene Polymorphism With Stevens-Johnson Syndrome Accompanied by Ocular Surface Complications

Investigative Ophthalmology and Visual Science
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2008English

Treatment of Atopic Dermatitis With Tralokinumab, an Anti–IL-13 Monoclonal Antibody

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

IL-20-receptor Signaling Delimits IL-17 Production in Psoriatic Inflammation

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy